Surgery – Diagnostic testing – Sampling nonliquid body material
Reexamination Certificate
2004-12-16
2010-12-21
Prouty, Rebecca E. (Department: 1657)
Surgery
Diagnostic testing
Sampling nonliquid body material
C600S420000
Reexamination Certificate
active
07854705
ABSTRACT:
An instrument for verification of presence of image enhancing, contrasting agent in a biopsy sample which was obtained by imaging the lesion area with an imaging modality which is sensitive to the contrasting agent. In one embodiment of the invention, an optical spectrometer is used to analyze biopsy samples for the presence of gadolinium enhanced Magnetic Resonance Imaging contrasting agent which typically pools in breast tumors.
REFERENCES:
patent: 4572203 (1986-02-01), Feinstein
patent: 4930516 (1990-06-01), Alfano et al.
patent: 5093106 (1992-03-01), Dzbanovsky et al.
patent: 5419323 (1995-05-01), Kittrell et al.
patent: 5869023 (1999-02-01), Ericcson et al.
patent: 6066102 (2000-05-01), Townsend et al.
patent: 6091985 (2000-07-01), Alfano et al.
patent: 6174291 (2001-01-01), McMahon et al.
patent: 6421553 (2002-07-01), Costa et al.
patent: 6521209 (2003-02-01), Meade et al.
patent: 6526299 (2003-02-01), Pickard
patent: 6593101 (2003-07-01), Richards-Kortum et al.
patent: 6697652 (2004-02-01), Georgakoudi et al.
patent: 6723303 (2004-04-01), Quay
patent: 2002/0164810 (2002-11-01), Dukor et al.
patent: 2003/0191397 (2003-10-01), Webb et al
patent: 2003/0199754 (2003-10-01), Hibner et al.
patent: 2004/0254445 (2004-12-01), Bittner
patent: WO00/68665 (2000-11-01), None
patent: WO 01/28412 (2001-04-01), None
patent: WO 2004/048988 (2004-06-01), None
Bugaj et al. Novel Fluorescent Contrast Agents for Optical Imaging of In Vivo Tumors Based on a Receptor-Targeted Dye-Peptide Conjugate Platform; Journal of Biomedical Optics, vol. 6, No. 2 (2001) pp. 122-133.
Young et al. Confidence Images for MR Spectrscopic Imaging; Magnetic Resonance in Medicine, vol. 44 (2000) pp. 537-545.
M. Kriege, C.T.M. Brekelmans, C. Boetes, J. Klijn, at al. “Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition.” N Engl J Med 2004; 351:427-437.
Gregory Palmer, et al. “Optimal Methods for Fluorescence and Diffuse Reflectance Measurements of Tissue Biopsy Samples” Lasers in Surgery and Medicine. 30:191-200 (2002).
Nicole Kline et al. “Raman Chemical Imaging of Breast Tissue” Journal of Raman Spectroscopy, vol. 28. 119-124 (1997).
Ramasamy Manoharan et al. “Histochemical Analysis of biological tissues using Raman Spectroscopy”, Spectrochimica Acta Part A..52 (1996) 215-249.
K. E. Shafer-Peltier, et al. “Raman microspectroscopic model of human breast tissue: implications for breast cancer diagnosis in vivo”. Journal of Raman Spectroscopy, 2002, 33:552-563.
Ntziachrstos V, et al. “Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement” PNAS, Mar. 14, 2000, vol. 97, No. 6, 2767-2772.
Pawluczyk Olga
Piron Cameron
Mark A Litman & Associates PA
Martin Paul C.
Prouty Rebecca E.
LandOfFree
Ex vivo verification of biopsy tissue samples does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ex vivo verification of biopsy tissue samples, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ex vivo verification of biopsy tissue samples will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4214576